Skip to main content
. 2020 Oct 8;70(4):1127–1142. doi: 10.1007/s00262-020-02725-2

Table 1.

Persistent symptoms and signs over two years following TGN1412-induced cytokine storm

Categories Symptoms and immune correlates (# of patients) CTCAE grade
Neurocognitive and psychological Memory impairment (6) 1–2
Impairment in attentional processing (6) 1–2
Mild-moderate depression (3) 1–2
Post-traumatic stress disorder (2) 2
Anxiety requiring psychotherapy (4) 1–3
Headaches (5) 1–2
Blurred vision (5) 1
Autoimmune and inflammatory Mild neutropenia (3) 1
Arthralgias—knees, hands, back (6) 1
Positive auto-antibodies (4) 1
Ischemic extremities (1) 3
Raynaud’s phenomenon (1) 1
Immune mucosal barrier function Diarrhea and ↑ γδT cells (3) 1–2
Skin dryness and ↑sensitivity (3) 1–2
Pruritus (1) 1–2
Peripheral blood eosinophilia (3) 1
↑ Serum IgE (4) 1
Benign lipomas/angiolipomas (1) 2
Immune cell subsets and cytokines Gradual recovery of DC over 1 month (6) 1
Low-normal total CD4+ T cells (5) 1
Low-normal total CD8+ T cells (6) 1
↑ sustained naïve CD8+ T cells (5) 1
↓ naïve CD4+ T cells over time (5) 1
↓ memory CD4+ T cells over time (4) 1
↓ memory CD8+ T cells over time (4) 1
Normal Tregs with circannual cycle (6) 1
Vβ repertoire normal (6)
Normal immune responses in vitro (6)
↑ sustained erythropoietin level for 3 months (1) 1
↑ cytokine response from 3 months (1) 1
IL-17 differences (6) 1

CTCAE common terminology criteria for adverse events, version 4.03